e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of the revised definition of extensively drug-resistant tuberculosis
Nicolas Veziris, Isabelle Bonnet, Florence Morel, Lorenzo Guglielmetti, Thomas Maitre, Laure Fournier Le Ray, Wladimir Sougakoff, Jérôme Robert, Alexandra Aubry
Source:
Eur Respir J, 58 (2) 2100641; 10.1183/13993003.00641-2021
Journal Issue:
August
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nicolas Veziris, Isabelle Bonnet, Florence Morel, Lorenzo Guglielmetti, Thomas Maitre, Laure Fournier Le Ray, Wladimir Sougakoff, Jérôme Robert, Alexandra Aubry. Impact of the revised definition of extensively drug-resistant tuberculosis. Eur Respir J, 58 (2) 2100641; 10.1183/13993003.00641-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Clinical and operational value of the extensively drug-resistant tuberculosis definition
Source: Eur Respir J 2007; 30: 623-626
Year: 2007
Clinical outcomes of patients with drug-resistant and extensively drug-resistant tuberculosis in Europe
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008
Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Source: Eur Respir J 2009; 33: 1085-1094
Year: 2009
Treatment options for patients with multidrug-resistant or extensively drug-resistant tuberculosis
Source: Annual Congress 2009 - Priorities in tuberculosis research
Year: 2009
Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan
Source: ERJ Open Res, 8 (1) 00551-2021; 10.1183/23120541.00551-2021
Year: 2022
An outbreak of extensively drug-resistant tuberculosis among a Portuguese family
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases
Source: Eur Respir J, 50 (1) 1700648; 10.1183/13993003.00648-2017
Year: 2017
Multidrug- and extensively drug-resistant tuberculosis: an emerging threat
Source: Eur Respir Rev 2009; 18: 195-197
Year: 2009
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Source: Eur Respir J 2014; 44: 23-63
Year: 2014
Risk factors for treatment failure in multidrug-resistant and extensively drug-resistant tuberculosis in Estonia
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
Risk factors for multidrug-resistant and extensively drug-resistant tuberculosis in Estonia
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city
Source: Eur Respir J 2013; 41: 901-908
Year: 2013
A case of resistance beyond extensively drug-resistant tuberculosis in Japan
Source: Eur Respir J 2013; 42: 872-873
Year: 2013
A case of resistance beyond extensively drug-resistant tuberculosis in Japan
Source: Eur Respir J 2013; 42: 870-872
Year: 2013
The WHO strategy for TB control and elimination
Source: Eur Respir Mon 2012; 58: 242-253
Year: 2012
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis
Source: Eur Respir J 2013; 42: 169-179
Year: 2013
Extensively drug-resistant tuberculosis: back to the future
Source: Eur Respir J 2010; 36: 475-477
Year: 2010
Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012
Epidemiology of TB
Source: Eur Respir Mon 2012; 58: 14-25
Year: 2012
Laboratory system to detect multidrug-resistant (MDR) and extensively drug-resistant (XDR)
mycobacterium tuberculosis
strains in clinical practice
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept